Profile data is unavailable for this security.
About the company
Giant Biogene Holding Co Ltd is a China-based investment holding company. The Company is principally engaged the research, development, manufacture and sale of bioactive material-based beauty and health products through its subsidiaries. The Company's main products include functional skincare products and medical dressings, and they are produced with recombinant collagen as the key bioactive ingredient. The Company also develops and manufactures rare ginsenosides technology-based functional foods. The Company mainly conducts its businesses within the domestic market.
- Revenue in HKD (TTM)4.92bn
- Net income in HKD1.95bn
- Incorporated2021
- Employees1.16k
- LocationGiant Biogene Holding Co LtdShanglin Yuan 7th RoadChang'An District, No. 1855XI'AN ChinaCHN
- Websitehttp://www.xajuzi.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kobayashi Pharmaceutical Co Ltd | 9.36bn | 752.94m | 24.00bn | 3.53k | 30.85 | 2.01 | 21.08 | 2.56 | 184.09 | 184.09 | 2,307.55 | 2,821.32 | 0.6542 | 2.67 | 4.74 | 48,943,410.00 | 5.26 | 8.01 | 6.41 | 10.18 | 54.72 | 56.45 | 8.04 | 12.24 | 2.21 | -- | 0.0054 | 33.19 | 4.33 | 0.7037 | 1.58 | 2.45 | 29.67 | 8.88 |
| Lion Corp | 22.11bn | 1.10bn | 24.19bn | 7.55k | 21.81 | 1.52 | 10.31 | 1.09 | 72.02 | 72.02 | 1,451.45 | 1,032.18 | 0.8584 | 3.76 | 5.81 | 54,107,680.00 | 4.79 | 5.63 | 7.04 | 8.93 | 45.30 | 47.60 | 5.59 | 6.45 | 1.20 | -- | 0.0963 | 31.01 | 3.31 | 2.88 | -33.34 | -10.60 | 9.21 | 5.39 |
| Hengan International Group Company Ltd | 25.81bn | 3.29bn | 25.51bn | 24.00k | 7.83 | 1.13 | 5.91 | 0.9886 | 2.86 | 2.86 | 22.44 | 19.79 | 0.4935 | 4.01 | 8.68 | 1,122,023.00 | 6.29 | 7.70 | 13.60 | 15.91 | 34.87 | 37.14 | 12.75 | 14.79 | 1.10 | 12.23 | 0.4955 | 65.99 | 5.09 | 2.99 | 45.46 | -5.92 | 15.95 | -9.05 |
| Kose Corp | 17.06bn | 788.99m | 26.40bn | 7.56k | 31.50 | 1.65 | 18.60 | 1.55 | 255.46 | 255.46 | 5,524.98 | 4,892.20 | 0.8482 | 1.22 | 7.24 | 41,709,980.00 | 4.24 | -- | 5.41 | -- | 69.99 | -- | 5.00 | -- | 2.78 | -- | 0.0358 | -- | 3.90 | -- | -37.87 | -- | -- | -- |
| Gillette India Limited | 2.46bn | 384.14m | 27.26bn | 571.00 | 70.96 | 30.08 | 59.10 | 11.10 | 126.35 | 126.35 | 808.08 | 298.07 | 1.41 | 2.73 | 8.86 | -- | 21.98 | 20.47 | 37.91 | 33.03 | 58.17 | 53.49 | 15.64 | 14.45 | 1.04 | 63.13 | 0.00005 | 73.85 | 6.30 | 7.18 | 15.75 | 10.24 | -2.28 | 15.39 |
| Emami Ltd | 3.41bn | 689.01m | 30.45bn | 3.29k | 44.19 | -- | 35.38 | 8.92 | 16.92 | 16.92 | 83.81 | -- | -- | -- | -- | 11,123,460.00 | -- | 20.43 | -- | 27.91 | 68.08 | 65.56 | 20.17 | 18.75 | -- | 52.01 | -- | 53.89 | 5.06 | 5.85 | 13.13 | 19.00 | -21.85 | 14.87 |
| Proya Cosmetics Co Ltd | 11.36bn | 1.54bn | 35.68bn | 2.97k | 23.57 | 7.07 | -- | 3.14 | 3.45 | 3.45 | 25.41 | 11.51 | 1.47 | 4.20 | 40.40 | 3,459,794.00 | 20.33 | 15.54 | 28.58 | 21.61 | 68.76 | 66.58 | 13.88 | 12.83 | 2.48 | -- | 0.1761 | 30.15 | 39.45 | 30.41 | 46.06 | 32.97 | -4.80 | 42.52 |
| Giant Biogene Holding Co Ltd | 4.92bn | 1.95bn | 39.89bn | 1.16k | 19.67 | 6.06 | 20.09 | 8.11 | 1.97 | 1.97 | 4.99 | 6.40 | 0.7649 | 2.96 | 31.08 | 4,224,746.00 | 30.24 | -- | 36.89 | -- | 82.74 | -- | 39.53 | -- | 3.62 | -- | 0.0002 | -- | 49.05 | -- | 44.88 | -- | -- | -- |
| Unilever Indonesia Tbk PT | 19.21bn | 2.32bn | 42.57bn | 4.55k | 18.36 | 28.99 | 15.13 | 2.22 | 118.17 | 118.17 | 979.38 | 74.86 | 1.88 | 7.61 | 10.66 | 8,141,927,000.00 | 22.73 | 31.40 | 82.67 | 88.33 | 50.20 | 50.45 | 12.07 | 14.85 | 0.4304 | 131.85 | 0.1643 | 101.38 | -6.33 | -1.58 | -10.51 | -11.97 | -4.74 | -9.99 |
| L'Occitane International S.A. | 22.11bn | 816.82m | 49.71bn | 9.26k | 60.99 | 6.67 | 21.33 | 2.25 | 0.5525 | 0.5525 | 14.97 | 5.05 | 0.8571 | 1.37 | 9.05 | 2,389,376.00 | 3.43 | 5.51 | 5.04 | 7.77 | 79.32 | 81.08 | 4.01 | 7.58 | 0.5264 | 5.70 | 0.4901 | 29.85 | 19.08 | 12.24 | -18.43 | -4.50 | -5.23 | -- |
| Procter & Gamble Hygiene & Health Care | 3.92bn | 629.83m | 50.02bn | 432.00 | 79.42 | 69.19 | 73.29 | 12.75 | 207.95 | 207.95 | 1,295.63 | 238.71 | 2.11 | 7.25 | 18.40 | -- | 33.79 | 33.42 | 69.94 | 62.37 | 61.62 | 52.13 | 16.05 | 16.20 | 0.9933 | 34.61 | 0.004 | 87.24 | 7.35 | 7.37 | -0.4601 | 10.00 | 22.65 | 17.25 |
Data as of Sep 20 2024. Currency figures normalised to Giant Biogene Holding Co Ltd's reporting currency: Hong Kong Dollar HKD
13.09%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| E Fund Management Co., Ltd.as of 11 Mar 2024 | 50.07m | 4.87% |
| Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 14.99m | 1.46% |
| The Vanguard Group, Inc.as of 31 Jul 2024 | 14.68m | 1.43% |
| China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 11.63m | 1.13% |
| Rosefinch Fund Management Co., Ltd.as of 31 Dec 2023 | 11.46m | 1.11% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 8.29m | 0.81% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 7.18m | 0.70% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 6.90m | 0.67% |
| BlackRock Fund Advisorsas of 05 Sep 2024 | 5.07m | 0.49% |
| Harvest Fund Management Co., Ltd.as of 31 Dec 2023 | 4.38m | 0.43% |
More ▼
Data from 31 Dec 2023 - 19 Sep 2024Source: FactSet Research Systems Inc.
